Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bimal K Agrawal

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Evidence-Based Medicine|December 2, 2009
Letter: looking at the bigger picture while treating type 2 diabetes mellitusBimal K Agrawal
The New England Journal of Medicine|March 21, 2014
Acute liver failureBimal K Agrawal, Usha Agrawal
The American Journal of Emergency Medicine|July 17, 2012
"Aluminium phosphide" toxicity is not due to "aluminium"Bimal K Agrawal, Vikas Deswal, Usha Agrawal
Clinical & Experimental Optometry|March 10, 2021
Leukaemic retinopathy in a patient with chronic myeloid leukaemiaSugandha Goel, Arnav Saroya, Bimal K Agrawal, et al.
Turkish Journal of Pharmaceutical Sciences|May 5, 2022
Vitamin D with Calcium Supplementation Managing Glycemic Control with HbA1c and Improve Quality of Life in Patients with DiabetesSanjana Mehta, Parminder Nain, Bimal K Agrawal, et al.
Journal of Emergencies, Trauma, and Shock|December 17, 2009
Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, IndiaSumeet Gupta, Bimal K Agrawal, Rajesh K Goel, et al.
Cureus|January 13, 2026
Correlation of Epicardial Fat Thickness With the Severity of Coronary Artery DiseaseKadappa B Nagoni, Rajesh Nandal, Manu Mathew, et al.
Journal of Medical Virology|March 23, 2021
Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemicsSasanka Chakrabarti, Sankha S Chakrabarti, Upinder Kaur, et al.
Frontiers in Aging Neuroscience|July 26, 2021
Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good EnoughUpasana Ganguly, Sukhpal Singh, Soumya Pal, et al.
European Journal of Pharmacology|July 1, 2022
Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's diseaseSukhpal Singh, Upasana Ganguly, Soumya Pal, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Evidence-Based Medicine|December 2, 2009
Letter: looking at the bigger picture while treating type 2 diabetes mellitusBimal K Agrawal
The New England Journal of Medicine|March 21, 2014
Acute liver failureBimal K Agrawal, Usha Agrawal
The American Journal of Emergency Medicine|July 17, 2012
"Aluminium phosphide" toxicity is not due to "aluminium"Bimal K Agrawal, Vikas Deswal, Usha Agrawal
Clinical & Experimental Optometry|March 10, 2021
Leukaemic retinopathy in a patient with chronic myeloid leukaemiaSugandha Goel, Arnav Saroya, Bimal K Agrawal, et al.
Turkish Journal of Pharmaceutical Sciences|May 5, 2022
Vitamin D with Calcium Supplementation Managing Glycemic Control with HbA1c and Improve Quality of Life in Patients with DiabetesSanjana Mehta, Parminder Nain, Bimal K Agrawal, et al.
Journal of Emergencies, Trauma, and Shock|December 17, 2009
Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, IndiaSumeet Gupta, Bimal K Agrawal, Rajesh K Goel, et al.
Cureus|January 13, 2026
Correlation of Epicardial Fat Thickness With the Severity of Coronary Artery DiseaseKadappa B Nagoni, Rajesh Nandal, Manu Mathew, et al.
Journal of Medical Virology|March 23, 2021
Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemicsSasanka Chakrabarti, Sankha S Chakrabarti, Upinder Kaur, et al.
Frontiers in Aging Neuroscience|July 26, 2021
Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good EnoughUpasana Ganguly, Sukhpal Singh, Soumya Pal, et al.
European Journal of Pharmacology|July 1, 2022
Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's diseaseSukhpal Singh, Upasana Ganguly, Soumya Pal, et al.
Pageof 2